Rheumatology
Conference Coverage
Inadequate pain relief in OA, high opioid use before TKA
Rates of inadequate pain relief in knee and hip OA, and high opioid use before total knee replacement surgery were reported in separate studies at...
Conference Coverage
COVID-19 infection linked to risk of cutaneous autoimmune and vascular diseases
“Our theory is that the severe inflammatory nature of COVID-19 leads to a lot of internal organ damage and exposure of autoantigens in that...
News
New MIS-C guidance addresses diagnostic challenges, cardiac care
New updates in this third version of the American College of Rheumatology’s guidance include a recommendation for dual therapy with IVIg and...
Conference Coverage
Absolute increase in Kawasaki CV risk remains small in long-term follow-up
Relative to controls, the increased long-term cardiovascular risk of patients with Kawasaki disease is small in most patients.
News
Updated guidance for COVID vaccination in rheumatology patients arrives amid continued hesitancy
A fifth update to the American College of Rheumatology’s guidelines makes new recommendations on supplemental and booster doses in patients with...
News
Allopurinol found safe in patients with concomitant gout, CKD
Despite earlier concerns, a study has found no sign of increased mortality with allopurinol therapy in patients with gout and chronic kidney...
News
How safe is a drug holiday from bisphosphonates for osteoporosis?
“We found little difference in the association between risedronate versus alendronate drug holidays and hip fractures until approximately 2 years...
News
Super-low uric acid may not be best for erosive gout
Lowering the target for uric acid levels from the current standard doesn’t result in better gout outcomes and leads to more medication use and...
News
Therapeutic aquatic exercise superior to physical therapy for back pain in study
Therapeutic aquatic exercise proved more beneficial than physical therapy in relieving symptoms and disability caused by chronic back pain.
Conference Coverage
mRNA COVID vaccine response found mostly robust in RA, SLE patients
A trial found that immunosuppressed adults with autoimmune disease had a robust antibody response to the mRNA vaccine with no excess adverse...